What data does the API provide for ATX?

Stored coverage for ATX: price data available, financial statements available, 1 archived filings. REST endpoints are under /api/v1/companies/ATX; inspect available source metadata for provenance.

How complete is ATX's financial data?

The anchor reporting period (FY2026) has 76.5% of the 17 core statement fields populated. Primary source: yfinance.

What reporting periods are covered for ATX?

4 fiscal-year periods are stored (FY2023–FY2026), with per-period field counts and source tags available via /api/v1/companies/ATX/financials.

Where does ATX's data come from?

Stored price source: yfinance. Primary source for the statement snapshot: yfinance. Inspect available period and field source tags at /api/v1/companies/ATX/financials; missing tags do not establish provenance.

--:--:--LOCAL ·--:--UTC

US EQUITIESLAST CLOSE

AAPL$344.63-1.23%

MSFT$521.91-1.55%

GOOGL$279.84-1.40%

AMZN$240.35-1.41%

NVDA$204.64-4.22%

META$614.99-1.53%

TSLA$399.81-0.87%

NFLX$62.08+0.05%

BRK.B$542.49+0.10%

AVGO$326.08-5.48%

DIS$110.94+0.03%

SBUX$103.67-1.74%

MCD$258.12+0.29%

NKE$38.67+0.65%

COST$1012.28+1.63%

WMT$123.51+1.86%

HD$329.20+0.07%

KO$94.08+1.36%

PG$161.57+0.61%

ORCL$130.67-6.37%

CRM$229.17-0.75%

ADBE$250.23+0.85%

AMD$504.80-10.88%

INTC$65.76-28.58%

QCOM$164.79-11.12%

CSCO$104.51-3.76%

IBM$257.81-0.18%

UBER$65.25-0.75%

ABNB$164.39-1.24%

SHOP$157.49-5.63%

PYPL$57.01+0.11%

COIN$143.54-10.62%

PLTR$184.11-6.27%

HOOD$84.99-7.21%

JPM$337.04-1.90%

V$413.59+0.74%

MA$638.01+0.36%

BAC$50.01-2.21%

GS$894.55-3.58%

LLY$1417.54+3.19%

UNH$406.97-0.96%

JNJ$273.20-0.73%

PFE$30.52+1.90%

XOM$187.25+2.16%

BA$171.55-0.64%

BABA$98.04-1.51%

TSM$406.13-5.95%

US EQUITIESLAST CLOSE

AAPL$344.63-1.23%

MSFT$521.91-1.55%

GOOGL$279.84-1.40%

AMZN$240.35-1.41%

NVDA$204.64-4.22%

META$614.99-1.53%

TSLA$399.81-0.87%

NFLX$62.08+0.05%

BRK.B$542.49+0.10%

AVGO$326.08-5.48%

DIS$110.94+0.03%

SBUX$103.67-1.74%

MCD$258.12+0.29%

NKE$38.67+0.65%

COST$1012.28+1.63%

WMT$123.51+1.86%

HD$329.20+0.07%

KO$94.08+1.36%

PG$161.57+0.61%

ORCL$130.67-6.37%

CRM$229.17-0.75%

ADBE$250.23+0.85%

AMD$504.80-10.88%

INTC$65.76-28.58%

QCOM$164.79-11.12%

CSCO$104.51-3.76%

IBM$257.81-0.18%

UBER$65.25-0.75%

ABNB$164.39-1.24%

SHOP$157.49-5.63%

PYPL$57.01+0.11%

COIN$143.54-10.62%

PLTR$184.11-6.27%

HOOD$84.99-7.21%

JPM$337.04-1.90%

V$413.59+0.74%

MA$638.01+0.36%

BAC$50.01-2.21%

GS$894.55-3.58%

LLY$1417.54+3.19%

UNH$406.97-0.96%

JNJ$273.20-0.73%

PFE$30.52+1.90%

XOM$187.25+2.16%

BA$171.55-0.64%

BABA$98.04-1.51%

TSM$406.13-5.95%

StockMarketAPI

Get API Key

Plug stock market data into your AI agent — one command: Get your free API key →

Company data coverage · ASX

ATX — AMPLIA THERAPEUTICS LIMITED

Data coverage, completeness and provenance for AMPLIA THERAPEUTICS LIMITED in the Stock Market API — Health Care · Biotechnology.

ASX AUS

Core-field completeness

76.5%

Statement periods

FY2023–FY2026

Filings archived

1 (1 md)

Price collection time

2026-11-01 07:02 UTC

Stored price coverage

Source date: 2026-10-30T05:10:11. Source: yfinance. Collection time is shown separately and does not establish a trade date.

Recent stored price bars, without investment interpretation
Date	Close	Currency	Source	Adjustment basis
2026-10-30	0.0840	AUD	yfinance	Split- and dividend-adjusted close
2026-10-29	0.0890	AUD	yfinance	Split- and dividend-adjusted close
2026-10-28	0.0830	AUD	yfinance	Split- and dividend-adjusted close
2026-10-27	0.0790	AUD	yfinance	Split- and dividend-adjusted close
2026-10-26	0.0780	AUD	yfinance	Split- and dividend-adjusted close

GET /api/v1/companies/ATX/prices · Price parameters and adjustment semantics

Dataset availability · Handle missing data

Profile

Amplia Therapeutics Limited, a clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its product pipeline comprises Narmafotinib (AMP945), an inhibitor of FAK, which is in phase 2b clinical trial for pancreatic cancer; and treatment of ovarian cancer. It also develops AMP886 for application in oncology and chronic fibrosis indications. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.

Website: https://www.ampliatx.com · Profile fields populated: 60%

Data completeness by statement

Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/ATX/financials.

Income statement7/10 fields (70.0%)

Balance sheet12/14 fields (85.7%)

Cash flow5/6 fields (83.3%)

Per-share3/4 fields (75.0%)

Financial statement coverage (AUD)

Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.

Period	Period end	Fields populated	Source
FY2026 (AUD)	2026-03-31	27	yfinance
FY2025 (AUD)	2025-03-31	26	yfinance
FY2024 (AUD)	2024-03-31	27	yfinance
FY2023 (AUD)	2023-03-31	27	yfinance

Get ATX data via the API

The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.

Company profile

Name, sector, industry, HQ, employees, market cap, source-tagged.

GET /api/v1/companies/ATX

Financial statements

Multi-year statements with per-field source tags and completeness.

GET /api/v1/companies/ATX/financials

Computed ratios

P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.

GET /api/v1/companies/ATX/metrics/summary

Filings archive

Report PDFs with LLM-ready markdown conversions where available.

GET /api/v1/companies/ATX/filings

News & announcements

Dated press releases and announcements with source links.

GET /api/v1/companies/ATX/news

Quick start

Create a free key, then:

curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/ATX

Query ATX programmatically

Free tier — instant API key. Built for AI agents.

API Docs AI Agent Setup

Other ASX · Health Care companies covered

AT1

ATOMO DIAGNOSTICS LIMITED

Fisher & Paykel Healthcare

Frequently Asked Questions

What data does the API provide for ATX?: Stored coverage for ATX: price data available, financial statements available, 1 archived filings. REST endpoints are under /api/v1/companies/ATX; inspect available source metadata for provenance.
How complete is ATX's financial data?: The anchor reporting period (FY2026) has 76.5% of the 17 core statement fields populated. Primary source: yfinance.
What reporting periods are covered for ATX?: 4 fiscal-year periods are stored (FY2023–FY2026), with per-period field counts and source tags available via /api/v1/companies/ATX/financials.
Where does ATX's data come from?: Stored price source: yfinance. Primary source for the statement snapshot: yfinance. Inspect available period and field source tags at /api/v1/companies/ATX/financials; missing tags do not establish provenance.